ArticleOncology reports2017

Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis.

Jun-Feng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.